Scott joined CDD in early 2022 to help refine and grow its new BioHarmony Data Services business. Scott has over 30 years of experience in the pharmaceutical research industry. His career has focused on the development and commercialization of informatics tools and services that improve the drug discovery & development process. Scott has served in multiple senior leadership roles including VP, GM at Tripos, Inc. a Computer Aided Molecular Design company, Co-Founder & CEO of ChemNavigator.com an online chemistry services company which was acquired by Sigma-Aldrich Inc., and Commercial Director of Elsevier Life Sciences Professional Services.
Clinical & Research Tools Showcase:
CDD’s advances science through better data management. It’s flagship product, CDD Vault®, is a hosted informatics solution that allows researchers to organize data and experiments and securely collaborate. CDD also offers the BioHarmony™ Drug Data Store, providing semantic data on preclinical, clinical, and post-approval developments.
ML for Drug Profiles & Bioassay Registration
FAIR commercial Drug profile data and new ML technology for the automated annotation and registration of bioassays.
The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.